BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38230960)

  • 1. Real-World Outcomes of Inoperable and Metastatic Cutaneous Head and Neck Melanoma Patients.
    Rozendorn N; Shutan I; Feinmesser G; Grynberg S; Hodadov H; Alon E; Asher N
    Laryngoscope; 2024 Jun; 134(6):2762-2770. PubMed ID: 38230960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
    Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
    Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma.
    Andtbacka RH; Agarwala SS; Ollila DW; Hallmeyer S; Milhem M; Amatruda T; Nemunaitis JJ; Harrington KJ; Chen L; Shilkrut M; Ross M; Kaufman HL
    Head Neck; 2016 Dec; 38(12):1752-1758. PubMed ID: 27407058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel Lymph Node Biopsy in Head and Neck Melanoma: Long-term Outcomes, Prognostic Value, Accuracy, and Safety.
    Hanks JE; Kovatch KJ; Ali SA; Roberts E; Durham AB; Smith JD; Bradford CR; Malloy KM; Boonstra PS; Lao CD; McLean SA
    Otolaryngol Head Neck Surg; 2020 Apr; 162(4):520-529. PubMed ID: 32041486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600-Mutated Metastatic Melanoma: Pooled Analysis of 4 Randomized Clinical Trials.
    Hauschild A; Larkin J; Ribas A; Dréno B; Flaherty KT; Ascierto PA; Lewis KD; McKenna E; Zhu Q; Mun Y; McArthur GA
    JAMA Oncol; 2018 Oct; 4(10):1382-1388. PubMed ID: 30073321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk and Survival of Patients with Head and Neck Cutaneous Melanoma: National Perspective.
    Al-Qurayshi Z; Hassan M; Srivastav S; Sperry S; Pagedar N; Hamner J; Kandil E
    Oncology; 2017; 93(1):18-28. PubMed ID: 28423377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor location predicts survival in cutaneous head and neck melanoma.
    Tseng WH; Martinez SR
    J Surg Res; 2011 May; 167(2):192-8. PubMed ID: 21176922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic score for patients with advanced melanoma treated with ipilimumab.
    Diem S; Kasenda B; Martin-Liberal J; Lee A; Chauhan D; Gore M; Larkin J
    Eur J Cancer; 2015 Dec; 51(18):2785-91. PubMed ID: 26597444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Adjuvant Radiation Therapy With Survival in Patients With Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Harris BN; Pipkorn P; Nguyen KNB; Jackson RS; Rao S; Moore MG; Farwell DG; Bewley AF
    JAMA Otolaryngol Head Neck Surg; 2019 Feb; 145(2):153-158. PubMed ID: 30570645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
    Golger A; Young DS; Ghazarian D; Neligan PC
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):442-7. PubMed ID: 17515502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant treatment for stage III and IV cutaneous melanoma.
    Gorry C; McCullagh L; O'Donnell H; Barrett S; Schmitz S; Barry M; Curtin K; Beausang E; Barry R; Coyne I
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012974. PubMed ID: 36648215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology.
    Ercelep O; Topcu TO; Bayoglu IV; Ekinci AS; Koca S; Kavgaci H; Ozcelik M; Alacacioglu A; Uzunoglu S; Bozkurt O; Ulas A; Aksoy A; Taskoylu BY; Gumussay O; Yaman S; Uysal M; Aydin D; Gumus M
    Tumour Biol; 2016 Sep; 37(9):12033-12038. PubMed ID: 27173124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world data on PD-1 inhibitor therapy in metastatic melanoma.
    Arheden A; Skalenius J; Bjursten S; Stierner U; Ny L; Levin M; Jespersen H
    Acta Oncol; 2019 Jul; 58(7):962-966. PubMed ID: 31151362
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative study of head and neck mucosal melanoma in 66 patients vs 226 patients with cutaneous melanoma: A survival analysis.
    Luna-Ortiz K; Villavicencio-Valencia V; Martinez Said H
    Clin Otolaryngol; 2018 Apr; 43(2):691-696. PubMed ID: 28986955
    [No Abstract]   [Full Text] [Related]  

  • 16. Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors.
    Waninger JJ; Ma VT; Journey S; Skvarce J; Chopra Z; Tezel A; Bryant AK; Mayo C; Sun Y; Sankar K; Ramnath N; Lao C; Sussman JB; Fecher L; Alva A; Green MD
    JAMA Netw Open; 2021 Mar; 4(3):e210980. PubMed ID: 33687443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
    Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR
    JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of treatment-naive Slovenian patients with metastatic melanoma treated with pembrolizumab - real-world experience.
    Hribernik N; Boc M; Ocvirk J; Knez-Arbeiter J; Mesti T; Ignjatovic M; Rebersek M
    Radiol Oncol; 2020 Jan; 54(1):119-127. PubMed ID: 31955148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of anti-programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma.
    Ogata D; Haydu LE; Glitza IC; Patel SP; Tawbi HA; McQuade JL; Diab A; Ekmekcioglu S; Wong MK; Davies MA; Amaria RN
    Cancer Med; 2021 Apr; 10(7):2293-2299. PubMed ID: 33686688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic Control.
    Alvarez-Breckenridge C; Giobbie-Hurder A; Gill CM; Bertalan M; Stocking J; Kaplan A; Nayyar N; Lawrence DP; Flaherty KT; Shih HA; Oh K; Batchelor TT; Cahill DP; Sullivan R; Brastianos PK
    Oncologist; 2019 May; 24(5):671-679. PubMed ID: 30796152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.